FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 28.4

Change

+0.69 (+2.49)%

Market Cap

N/A

Volume

0.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+1.76 (+1.43%)

USD 19.16B
VOT Vanguard Mid-Cap Growth Index ..

+3.43 (+1.36%)

USD 16.53B
IJK iShares S&P Mid-Cap 400 Growth..

+1.35 (+1.58%)

USD 9.61B
XMMO Invesco S&P MidCap Momentum ET..

+1.51 (+1.29%)

USD 4.68B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+1.64 (+1.54%)

USD 1.15B
CWS AdvisorShares Focused Equity E..

+0.43 (+0.65%)

USD 0.18B
ETHO Amplify ETF Trust

+0.75 (+1.32%)

USD 0.18B
IPO Renaissance IPO ETF

+0.20 (+0.50%)

USD 0.16B
BFOR Barron's 400 ETF

+0.42 (+0.60%)

USD 0.16B
PEXL Pacer US Export Leaders ETF

+0.84 (+1.79%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.66% 88% B+ 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.66% 88% B+ 38% F
Trailing 12 Months  
Capital Gain 4.49% 56% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.49% 56% F 41% F
Trailing 5 Years  
Capital Gain -13.20% 6% D- 29% F
Dividend Return 2.62% 17% F 6% D-
Total Return -10.59% 6% D- 16% F
Average Annual (5 Year Horizon)  
Capital Gain -1.41% 11% F 25% F
Dividend Return -0.73% 11% F 17% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 29.92% 22% F 35% F
Risk Adjusted Return -2.42% 11% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.